Mingnam Tang

USPTO Granted Patents = 13 (Patent Applications = 7)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 6.8

ph-index = 3

Forward Citations = 30(Granted Patents)

Company Filing History:

6 out of 53

Takeda San Diego, Inc.

patents

5 out of 1,177

Takeda Pharmaceutical Company Limited

patents

2 out of 2

Takeda California, Inc.

patents

Years Active: 2011-2025

where 'Filed Patents' based on already Granted Patents

13 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12428403 - N-(heterocyclyl and heterocyclylalkyl)-3-benzylpyridin-2-amine derivatives as SSTR4 agonists (2025-09-30),

2. 12005054 - Piperidinyl-3-(aryloxy)propanamides and propanoates (2024-06-11),

3. 11045457 - Piperidinyl-3-(aryloxy)propanamides and propanoates (2021-06-29),

4. 9475816 - Substituted-1,4-dihydropyrazolo[4,3-b]indoles (2016-10-25),

5. 9434743 - Indazole derivatives (2016-09-06),

6. 9139598 - Glucokinase activators (2015-09-22),

7. 8563730 - Pyrazole and fused pyrazole glucokinase activators (2013-10-22),

8. 8530499 - Glucokinase activators (2013-09-10),

9. 8394843 - Substituted isoindoles as glucokinase activators (2013-03-12),

10. 8173645 - Glucokinase activators (2012-05-08),

11. 8163779 - Glucokinase activators (2012-04-24),

12. 8034822 - Glucokinase activators (2011-10-11),

13. 8008332 - Substituted indazoles as glucokinase activators (2011-08-30),

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with the article about the inventor Mingnam Tang based on the given data.

Title: The Inventive Mind of Mingnam Tang: Revolutionizing Pharmaceuticals in San Diego

Introduction:

Mingnam Tang, a distinguished inventor, has left an indelible mark on the field of pharmaceuticals, with a stronghold in San Diego, CA. His innovative spirit and prolific work have led to numerous patents that have the potential to revolutionize medical treatments.

Latest Patents:

Among his latest patents are groundbreaking innovations such as Piperidinyl-3-(aryloxy)propanamides and propanoates. These compounds, as defined in the specification, hold significant promise in treating diseases associated with SSTR4. Additionally, his work on Substituted-1,4-dihydropyrazolo[4,3-b]indoles showcases his dedication to combating obesity and related conditions associated with MetAP2.

Career Highlights:

Mingnam Tang's career has been adorned with 11 patents, each representing a step forward in medical innovation. Notably, he has made substantial contributions during his tenure at Takeda San Diego, Inc., and Takeda Pharmaceutical Company Limited, where his inventive prowess shone brightly.

Collaborations:

In his journey of innovation, Mingnam Tang has collaborated with esteemed professionals such as Zacharia S Cheruvallath and Stephen L Gwaltney. These collaborations have not only enriched his work but have also paved the way for collective advancements in the realm of pharmaceuticals.

Conclusion:

In conclusion, Mingnam Tang stands as a beacon of ingenuity in San Diego, CA, with a remarkable portfolio of patents that have the potential to transform medical treatments. His dedication to creating novel solutions for prevalent diseases underscores his pivotal role in the world of innovation.

This text is generated by artificial intelligence and may not be accurate.